Lyophilized Sterile Vial
Tested: 99.3% (Tesa) / 99.5% (Ipam) / 99.1% (MGF)
Current Lot: MV-2026-SCL12-01
Multi-Peptide Precision Synergy
Sculpt Body Composition Blend (Tesamorelin + Ipamorelin + MGF)
12mg / 5mL (6mg Tesa / 4mg Ipam / 2mg MGF) • HPLC Purity: 99.3% (Tesa) / 99.5% (Ipam) / 99.1% (MGF) • Target: ≥ 99.0% per component
Triple-action investigative formulation linking lipolytic GHRH signaling, selective GH secretagogue stimulation, and local muscle satellite cell activation peptide (MGF).
Wholesale Commercial Pricing
Verified Provider Portal Required
• No consumer checkout • Tiered volume schedules • Certificate included with shipment
Formula Triple Action Anabolic Matrix
Molecular Weight Co-Lyophilized Formulation
CAS Registry # 218949-48-5 / 170851-70-4 / MGF
Peptide Sequence / Structure Tesamorelin (6mg) + Ipamorelin (4mg) + Mechano Growth Factor (2mg)
Current Lot Verification
Historical Lot Archive → Lot #MV-2026-SCL12-01 Analytical Results
Independent laboratory testing panel for active distribution batch.
| Analysis Category | Reported Result | Analytical Method | Verification Status |
|---|---|---|---|
| Tesamorelin Quantification | 6.05 mg (99.3%) | LC-MS/MS | Conforms |
| Ipamorelin Quantification | 4.02 mg (99.5%) | RP-HPLC | Conforms |
| MGF Quantification | 2.01 mg (99.1%) | RP-HPLC | Conforms |
| Endotoxin | < 0.05 EU/mg | USP <85> | Conforms |
Biological Mechanism of Action
Promotes adipocyte triglyceride lipolysis via enhanced GH pulsatility while stimulating satellite cell proliferation in muscle tissue models.
Research Focus Areas: Body Composition Satellite Cell Proliferation Lipolytic Signaling
Scientific Literature Cross-Reference
Explore primary peer-reviewed papers, PubMed indexes, and pharmacology data for Sculpt Blend.